Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126217791 | 12621779 | 1 | I | 20130110 | 20150707 | 20160804 | 20160804 | EXP | US-JNJFOC-20150705196 | JANSSEN | 63.45 | YR | A | F | Y | 89.62000 | KG | 20160804 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126217791 | 12621779 | 1 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | FREQUENCY: ON DAYS 1, 4, 8 AND 11. | N | UNKNOWN | 0 | 1.8 | MG | LYOPHILIZED POWDER | |||||
126217791 | 12621779 | 2 | PS | DOXIL | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | FREQUENCY: DAY 4 OF BORTEZOMIB TREATMENT. | N | UNKNOWN | 50718 | 59 | MG | LIPOSOME INJECTION | Q3W | ||||
126217791 | 12621779 | 3 | SS | DECADRON | DEXAMETHASONE | 1 | Oral | 0 | 40 | MG | UNKNOWN | ||||||||
126217791 | 12621779 | 4 | C | ZOMETA | ZOLEDRONIC ACID | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
126217791 | 12621779 | 5 | C | KYTRIL | GRANISETRON HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
126217791 | 12621779 | 6 | C | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
126217791 | 12621779 | 7 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
126217791 | 12621779 | 8 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126217791 | 12621779 | 1 | Plasma cell myeloma |
126217791 | 12621779 | 2 | Plasma cell myeloma |
126217791 | 12621779 | 3 | Plasma cell myeloma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126217791 | 12621779 | OT |
126217791 | 12621779 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126217791 | 12621779 | Anaemia | |
126217791 | 12621779 | Plasmacytoma | |
126217791 | 12621779 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126217791 | 12621779 | 1 | 20121213 | 20130107 | 0 | |
126217791 | 12621779 | 2 | 20121213 | 20130107 | 0 | |
126217791 | 12621779 | 3 | 20121213 | 20130107 | 0 |